Authors
Inga Savelyeva, Nikolay Govorov, Margaret Gradova, Olga Gruznova, Natalia Karpechenko, Irina Chesnokova, Dmitry Gruznov, Nikolay Popov, Gulizar Shcherbakova, Ekaterina Shuteeva, Nikolay Kuvshinchikov, Valeriya Tyumentseva, Arseniy Aybush, Maria Syrchina, Viktoriya Pchelkina, Alina Markova, Larisa Smolyaninova, Nikolay Pervushin, Olga Bezborodova, Natal'ya Bragina, Kseniya Zhdanova
Published in
Journal of medicinal chemistry. Jul 20, 2026. Epub Jul 20, 2026.
Abstract
This work describes the synthesis of new cationic ABAB- and A4-type porphyrins for photodynamic therapy (PDT) of infectious disease and malignant tumors. Pluronic F127 has been chosen as a delivery vehicle for monomolecular photoactive forms of the porphyrins. The use of Pluronic F127 as a drug delivery system for compounds resulted in a 10-70-fold increase in photoinduced nanomolar toxicity compared to the free porphyrin as well as a high IC50 dark/IC50 light ratio of ∼1800 for one of the compounds. Microbiological studies showed inhibitory properties against S. aureus (strain 209-P) for all the tested compounds. MIC and effective concentrations (>2 × MIC) were determined. A positive effect of irradiation on the antimicrobial properties of porphyrins in both free and polymeric forms was established. The influence of porphyrins on the cell wall was determined using LSCM and SEM microscopy. The synthesized compounds are highly effective photosensitizers for both antimicrobial and antitumor photodynamic therapy.
PMID:
42475545
Bibliographic data and abstract were imported from PubMed on 21 Jul 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 8
- Comments 0